Jorrit De Waele

2.1k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Jorrit De Waele is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jorrit De Waele has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Jorrit De Waele's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (6 papers). Jorrit De Waele is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (6 papers). Jorrit De Waele collaborates with scholars based in Belgium, Australia and Uganda. Jorrit De Waele's co-authors include Evelien Smits, Filip Lardon, Patrick Pauwels, Julie Jacobs, Jonas R.M. Van Audenaerde, An Wouters, Marc Peeters, Christophe Deben, Eva Lion and Elly Marcq and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Jorrit De Waele

33 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential and controversy of targeting STAT family members in cancer

2019 273 citations Yannick Verhoeven, Sam Tilborghs et al. Seminars in Cancer Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorrit De Waele Belgium	19	594	525	470	267	168	36	1.4k
Tao Shi China	16	548 0.9×	490 0.9×	419 0.9×	170 0.6×	79 0.5×	39	1.2k
Zhengyun Zou China	21	810 1.4×	420 0.8×	855 1.8×	272 1.0×	115 0.7×	95	1.7k
Weiye Deng United States	19	623 1.0×	377 0.7×	419 0.9×	381 1.4×	136 0.8×	43	1.5k
Danny N. Khalil United States	14	950 1.6×	637 1.2×	410 0.9×	274 1.0×	93 0.6×	40	1.6k
Shailendra K. Gautam United States	18	469 0.8×	334 0.6×	543 1.2×	130 0.5×	102 0.6×	30	1.1k
Weiheng Zhao China	16	1.1k 1.8×	478 0.9×	723 1.5×	423 1.6×	120 0.7×	29	1.9k
Katyayani Tatiparti United States	14	1.0k 1.7×	601 1.1×	871 1.9×	243 0.9×	182 1.1×	19	2.3k
Yuzhu Hou China	21	663 1.1×	1.1k 2.1×	689 1.5×	239 0.9×	105 0.6×	42	2.0k
Julie Jacobs Belgium	19	760 1.3×	376 0.7×	513 1.1×	267 1.0×	122 0.7×	33	1.4k
Turid Hellevik Norway	19	631 1.1×	329 0.6×	524 1.1×	169 0.6×	137 0.8×	26	1.4k

Countries citing papers authored by Jorrit De Waele

Since Specialization

Citations

This map shows the geographic impact of Jorrit De Waele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorrit De Waele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorrit De Waele more than expected).

Fields of papers citing papers by Jorrit De Waele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorrit De Waele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorrit De Waele. The network helps show where Jorrit De Waele may publish in the future.

Co-authorship network of co-authors of Jorrit De Waele

This figure shows the co-authorship network connecting the top 25 collaborators of Jorrit De Waele. A scholar is included among the top collaborators of Jorrit De Waele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorrit De Waele. Jorrit De Waele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.

Wouters, An, et al.. (2025). Powering immunity: mitochondrial dynamics in natural killer cells. Trends in Molecular Medicine. 32(1). 49–64. 2 indexed citations

Privat‐Maldonado, Angela, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2025). Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation. Cells. 14(6). 450–450. 2 indexed citations

Yusupov, Maksudbek, et al.. (2024). Effect of plasma-induced oxidation on NK cell immune checkpoint ligands: A computational-experimental approach. Redox Biology. 77. 103381–103381.

Campillo-Davó, Diana, et al.. (2023). One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation. STAR Protocols. 4(1). 102112–102112. 1 indexed citations

Siozopoulou, Vasiliki, Christophe Hermans, Hilde Lambrechts, et al.. (2022). The prognostic impact of the immune signature in head and neck squamous cell carcinoma. Frontiers in Immunology. 13. 1001161–1001161. 13 indexed citations

Lin, Abraham, Jorrit De Waele, Joey De Backer, et al.. (2022). Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma. Drug Resistance Updates. 67. 100914–100914. 17 indexed citations

Flieswasser, Tal, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2022). The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research. 41(1). 12–12. 109 indexed citations

Winter, Hans De, Paul Cos, María João Matos, et al.. (2021). Molecular Docking Study of Flavonoids to Block the Aryl Hydrocarbon Receptor. SHILAP Revista de lepidopterología. 77–77. 4 indexed citations

10.

Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2021). Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biology. 42. 101949–101949. 85 indexed citations

11.

Pauw, Ines De, Marc Peeters, Jan B. Vermorken, et al.. (2021). The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies. Frontiers in Immunology. 12. 737311–737311. 39 indexed citations

12.

Marcq, Elly, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2021). The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers. 13(2). 282–282. 23 indexed citations

13.

Audenaerde, Jonas R.M. Van, Elly Marcq, Bianca von Scheidt, et al.. (2020). Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clinical & Translational Immunology. 9(8). e1165–e1165. 28 indexed citations

14.

Pauw, Ines De, Jorrit De Waele, Marc Peeters, et al.. (2020). Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status. British Journal of Cancer. 123(5). 752–761. 29 indexed citations

15.

Verhoeven, Yannick, Sam Tilborghs, Julie Jacobs, et al.. (2019). The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology. 60. 41–56. 273 indexed citations breakdown →

16.

Deben, Christophe, Vanessa Deschoolmeester, Jorrit De Waele, et al.. (2018). Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress. Cancers. 10(4). 126–126. 46 indexed citations

17.

Waele, Jorrit De, Elly Marcq, Jonas R.M. Van Audenaerde, et al.. (2017). Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade. OncoImmunology. 7(3). e1407899–e1407899. 36 indexed citations

18.

Marcq, Elly, Jorrit De Waele, Jonas R.M. Van Audenaerde, et al.. (2017). Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients. Oncotarget. 8(52). 89722–89735. 45 indexed citations

19.

Waele, Jorrit De, Kristien Reekmans, Jasmijn Daans, et al.. (2014). 3D culture of murine neural stem cells on decellularized mouse brain sections. Biomaterials. 41. 122–131. 75 indexed citations

20.

Waele, Jorrit De, Yannick Willemen, Ilse Van Brussel, et al.. (2014). Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs. Pharmacology & Therapeutics. 146. 120–131. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact